Search research articles
Contact Us
Filters
Showing results (351-360 of 372) with videos related to
Page
of 38
Sort By:
The Lancet. Respiratory Medicine
|
November 17, 2019
Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial
Conor D Tweed, Rodney Dawson, Divan A Burger, et al.
The Lancet. Infectious Diseases
|
December 4, 2018
Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial
Sinead Delany-Moretlwe, Carl Lombard, Deborah Baron, et al.
BJU International
|
March 6, 2018
Impact of hospital volume and surgeon volume on robot-assisted partial nephrectomy outcomes: a multicentre study
Benoît Peyronnet, Lauranne Tondut, Jean-Christophe Bernhard, et al.
Scientific Reports
|
March 30, 2021
Mass molecular testing for COVID19 using NGS-based technology and a highly scalable workflow
Fernanda de Mello Malta, Deyvid Amgarten, Felipe Camilo Val, et al.
Trials
|
June 6, 2023
A phase IIb, open-label, randomized controlled dose ranging multi-centre trial to evaluate the safety, tolerability, pharmacokinetics and exposure-response relationship of different doses of delpazolid in combination with bedaquiline delamanid moxifloxacin in adult subjects with newly diagnosed, uncomplicated, smear-positive, drug-sensitive pulmonary tuberculosis
A Dierig, M Hoelscher, S Schultz, et al.
Journal of Economic Entomology
|
September 13, 2022
Standardized Field Trials in Cotton and Bioassays to Evaluate Resistance of Tobacco Thrips (Thysanoptera: Thripidae) to Insecticides in the Southern United States
Jessica L Krob, Scott D Stewart, Sebe A Brown, et al.
Progress in Community Health Partnerships : Research, Education, and Action
|
November 7, 2023
Moving From Transactional to Relational: How Funders Can Work in Partnership With Black, Indigenous and People of Color Communities
Donald Cameron, Hazel Cameron, Jackie An, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 5, 2020
Phase 1 Human Immunodeficiency Virus (HIV) Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Subtype C DNA and MF59-Adjuvanted Subtype C Envelope Protein
Mina C Hosseinipour, Craig Innes, Sarita Naidoo, et al.
Urologic Oncology
|
October 4, 2016
Localized chromophobe carcinomas treated by nephron-sparing surgery have excellent oncologic outcomes
Pierre Bigot, Jean-Christophe Bernhard, Vincent Flamand, et al.
Progress in Community Health Partnerships : Research, Education, and Action
|
April 29, 2024
Moving From Transactional to Relational: How Funders Can Work in Partnership With Black, Indigenous and People of Color Communities
Donald Cameron, Hazel Cameron, Jackie An, et al.
Page
of 38
Search research articles
Search
Showing results (351-360 of 372) with videos related to
Sort By:
Page
of 38
The Lancet. Respiratory Medicine
|
November 17, 2019
Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial
Conor D Tweed, Rodney Dawson, Divan A Burger, et al.
The Lancet. Infectious Diseases
|
December 4, 2018
Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial
Sinead Delany-Moretlwe, Carl Lombard, Deborah Baron, et al.
BJU International
|
March 6, 2018
Impact of hospital volume and surgeon volume on robot-assisted partial nephrectomy outcomes: a multicentre study
Benoît Peyronnet, Lauranne Tondut, Jean-Christophe Bernhard, et al.
Scientific Reports
|
March 30, 2021
Mass molecular testing for COVID19 using NGS-based technology and a highly scalable workflow
Fernanda de Mello Malta, Deyvid Amgarten, Felipe Camilo Val, et al.
Trials
|
June 6, 2023
A phase IIb, open-label, randomized controlled dose ranging multi-centre trial to evaluate the safety, tolerability, pharmacokinetics and exposure-response relationship of different doses of delpazolid in combination with bedaquiline delamanid moxifloxacin in adult subjects with newly diagnosed, uncomplicated, smear-positive, drug-sensitive pulmonary tuberculosis
A Dierig, M Hoelscher, S Schultz, et al.
Journal of Economic Entomology
|
September 13, 2022
Standardized Field Trials in Cotton and Bioassays to Evaluate Resistance of Tobacco Thrips (Thysanoptera: Thripidae) to Insecticides in the Southern United States
Jessica L Krob, Scott D Stewart, Sebe A Brown, et al.
Progress in Community Health Partnerships : Research, Education, and Action
|
November 7, 2023
Moving From Transactional to Relational: How Funders Can Work in Partnership With Black, Indigenous and People of Color Communities
Donald Cameron, Hazel Cameron, Jackie An, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 5, 2020
Phase 1 Human Immunodeficiency Virus (HIV) Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Subtype C DNA and MF59-Adjuvanted Subtype C Envelope Protein
Mina C Hosseinipour, Craig Innes, Sarita Naidoo, et al.
Urologic Oncology
|
October 4, 2016
Localized chromophobe carcinomas treated by nephron-sparing surgery have excellent oncologic outcomes
Pierre Bigot, Jean-Christophe Bernhard, Vincent Flamand, et al.
Progress in Community Health Partnerships : Research, Education, and Action
|
April 29, 2024
Moving From Transactional to Relational: How Funders Can Work in Partnership With Black, Indigenous and People of Color Communities
Donald Cameron, Hazel Cameron, Jackie An, et al.
Page
of 38